v3.25.2
EQUITY (Details Narrative)
 1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 09, 2024
USD ($)
$ / shares
shares
Dec. 09, 2024
CNY (¥)
shares
Feb. 27, 2023
USD ($)
$ / shares
shares
Feb. 27, 2023
CNY (¥)
shares
Aug. 26, 2021
USD ($)
Aug. 26, 2021
CNY (¥)
Jul. 23, 2021
USD ($)
$ / shares
shares
Jul. 23, 2021
CNY (¥)
shares
Mar. 18, 2020
USD ($)
$ / shares
shares
Mar. 18, 2020
CNY (¥)
shares
Jul. 25, 2018
USD ($)
$ / shares
shares
Jan. 31, 2024
USD ($)
shares
Jan. 31, 2024
CNY (¥)
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Jul. 31, 2022
shares
Nov. 30, 2024
USD ($)
$ / shares
shares
Mar. 31, 2024
USD ($)
shares
Jun. 30, 2025
$ / shares
shares
May 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Ordinary shares, shares authorized | shares                               500,000,000     500,000,000          
Ordinary shares, par value | $ / shares                               $ 0.0001     $ 0.0001          
Number of shares issued, value | $                                              
Additional paid-in capital | $                               $ (0)     $ (0)          
Stockholders equity description                               On October 4, 2024, the Company issued one (1) ordinary share to Appleby Global Services (Cayman) Limited, on the same day, the one (1) ordinary share was transferred from Appleby Global Services (Cayman) Limited to XXW Investment Limited.     On October 4, 2024, the Company issued one (1) ordinary share to Appleby Global Services (Cayman) Limited, on the same day, the one (1) ordinary share was transferred from Appleby Global Services (Cayman) Limited to XXW Investment Limited.          
Ordinary shares, shares outstanding | shares                               1     1          
Ordinary shares, shares issued | shares                               1     1          
Common Stock [Member]                                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Number of shares issued | shares                               1                
Number of shares issued, value | $                               $ 0                
Maius Pharmaceutical Co. Ltd [Member]                                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Ordinary shares, shares authorized | shares                     50,000     50,000             50,000 50,000 50,000  
Ordinary shares, par value | $ / shares                     $ 1.00     $ 1             $ 1.00 $ 1 $ 1  
Number of shares issued, value | $                                         $ 30,776 $ 46,112    
Additional paid-in capital | $                           $ 11,074,192             11,074,192 11,074,192 $ 13,160,402  
Payments for shares transfer         $ 314,364 ¥ 2,060,221                                    
Subscription receivables | $                           $ 2,969,955             $ 2,939,179 $ 2,969,955 $ 2,939,179  
Ordinary shares, shares outstanding | shares                           13,727             13,727 13,727 14,619  
Ordinary shares, shares issued | shares                           13,727             13,727 13,727 14,619  
Maius Pharmaceutical Co. Ltd [Member] | Common Stock [Member]                                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Number of shares issued | shares                                           1,236    
Number of shares issued, value | $                                         $ 1,236    
Maius Pharmaceutical Co. Ltd [Member] | Wong Kin Hong [Member]                                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Number of shares issued | shares     1,236 1,236                                        
Number of shares issued, value     $ 2,985,286 ¥ 20,769,231                   $ 46,197                    
Capital | $     1,236                                          
Additional paid-in capital | $     $ 2,984,050                                          
Share price | $ / shares     $ 1.00                                          
Remaining unpaid amount | $                           $ 2,939,179                    
Maius Pharmaceutical Co. Ltd [Member] | Wishluck Limited [Member]                                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Number of shares issued | shares 892 892                                            
Number of shares issued, value $ 2,087,102 ¥ 15,000,000                                            
Capital | $ 892                                              
Additional paid-in capital | $ $ 2,086,210                                              
Share price | $ / shares $ 1.00                                              
Maius Pharmaceutical Co. Ltd [Member] | GZY GROUP LIMITED [Member]                                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Ordinary shares, par value | $ / shares                     $ 1.00                          
Number of shares issued | shares                     10,000                          
Number of shares issued, value | $                     $ 10,000                          
Maius Pharmaceutical Co. Ltd [Member] | SHIMF INVESTMENT LIMITED [Member]                                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Ordinary shares, par value | $ / shares                     $ 1.00                          
Number of shares issued | shares                     10,000                          
Number of shares issued, value | $                     $ 10,000                          
Maius Pharmaceutical Co. Ltd [Member] | Depth Way Corporation [Member]                                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Ordinary shares, par value | $ / shares                     $ 1.00                          
Number of shares issued | shares                     10,000                          
Number of shares issued, value | $                     $ 10,000                          
Maius Pharmaceutical Co. Ltd [Member] | STAR SPARKLING LIMITED [Member]                                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Ordinary shares, par value | $ / shares                     $ 1.00                          
Number of shares issued | shares                     10,000                          
Number of shares issued, value | $                     $ 10,000                          
Maius Pharmaceutical Co. Ltd [Member] | Petrochemical Engineering Limited [Member]                                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Ordinary shares, par value | $ / shares                 $ 1.00                              
Number of shares issued | shares                 1,111 1,111                            
Number of shares issued, value                 $ 1,419,507 ¥ 10,000,000                            
Capital | $                 1,111                              
Additional paid-in capital | $                 $ 1,418,396                              
Maius Pharmaceutical Co. Ltd [Member] | Wishluck Limited [Member]                                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Ordinary shares, par value | $ / shares             $ 1.00                                  
Number of shares issued | shares             556 556                                
Number of shares issued, value             $ 1,543,234 ¥ 10,000,000                                
Capital | $             556                                  
Additional paid-in capital | $             $ 1,542,678                                  
Maius Pharmaceutical Co. Ltd [Member] | ELITE RAINBOW LIMITED [Member]                                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Number of shares issued | shares     824 824               824 824                      
Number of shares issued, value     $ 30,741                 $ 1,990,191 ¥ 13,846,154                      
Capital | $     824                                          
Additional paid-in capital | $     $ 29,917                                          
Share price | $ / shares     $ 1.00                                          
Consultant fees | $                       30,741                        
Payments to financial advisor | $                       $ 1,959,450                        
DT Cloud Acquisition Corporation [Member]                                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Ordinary shares, shares authorized | shares                                   500,000,000   500,000,000       500,000,000
Ordinary shares, par value | $ / shares                                   $ 0.0001   $ 0.0001       $ 0.0001
Number of shares issued | shares                             1,725,000                  
Number of shares issued, value | $                                 $ 66,023,894     $ 66,023,894        
Additional paid-in capital | $                                             $ 24,827
Ordinary shares, shares outstanding | shares                                   2,063,000   2,063,000       1,725,000
Common stock rights                                   Each holder of a right will receive one-seventh (1/7) ordinary share upon consummation of a Business Combination, even if the holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued upon exchange of the rights.   Each holder of a right will receive one-seventh (1/7) ordinary share upon consummation of a Business Combination, even if the holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued upon exchange of the rights        
Ordinary shares, shares issued | shares                                   2,063,000   2,063,000       1,725,000
Temporary equity, shares issued | shares                                   832,415   6,900,000       0
Temporary equity, shares outstanding | shares                                   832,415   6,900,000       0
DT Cloud Acquisition Corporation [Member] | Common Stock [Member]                                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                                
Ordinary shares, shares authorized | shares                                   500,000,000   500,000,000        
Ordinary shares, par value | $ / shares                                   $ 0.0001   $ 0.0001        
Number of shares issued | shares                                 6,900,000     6,900,000        
Number of shares issued, value | $                                 $ 690     $ 690        
Ordinary shares, shares outstanding | shares                                   2,063,000   2,063,000       1,725,000
Common stock rights                                   Holders of the Company’s ordinary shares are entitled to one vote for each share   Holders of the Company’s ordinary shares are entitled to one vote for each share        
Ordinary shares, shares issued | shares                                       2,063,000       1,725,000